Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nephrectomy | 6 | 2015 | 949 | 0.810 |
Why?
|
| Cystectomy | 5 | 2015 | 644 | 0.790 |
Why?
|
| Laparoscopy | 6 | 2014 | 2056 | 0.770 |
Why?
|
| Prostatectomy | 5 | 2014 | 1840 | 0.760 |
Why?
|
| Urologic Neoplasms | 4 | 2014 | 319 | 0.620 |
Why?
|
| Kidney Neoplasms | 6 | 2023 | 4299 | 0.520 |
Why?
|
| Carcinoma, Renal Cell | 4 | 2023 | 3198 | 0.500 |
Why?
|
| Urinary Bladder Neoplasms | 4 | 2015 | 2254 | 0.480 |
Why?
|
| Ureteral Obstruction | 2 | 2013 | 297 | 0.440 |
Why?
|
| Prostatic Neoplasms | 7 | 2014 | 11206 | 0.430 |
Why?
|
| Kidney Pelvis | 2 | 2013 | 195 | 0.420 |
Why?
|
| Prostate-Specific Antigen | 3 | 2014 | 2483 | 0.400 |
Why?
|
| Consumer Health Information | 1 | 2014 | 215 | 0.380 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2010 | 78 | 0.350 |
Why?
|
| Nephrons | 1 | 2011 | 168 | 0.340 |
Why?
|
| Robotics | 2 | 2013 | 826 | 0.340 |
Why?
|
| Choice Behavior | 1 | 2014 | 846 | 0.290 |
Why?
|
| Urologic Surgical Procedures | 3 | 2014 | 299 | 0.280 |
Why?
|
| Luteinizing Hormone | 1 | 2009 | 821 | 0.270 |
Why?
|
| Carcinoma | 2 | 2014 | 2341 | 0.260 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2009 | 389 | 0.250 |
Why?
|
| Urinary Bladder | 4 | 1999 | 1160 | 0.240 |
Why?
|
| Disease Management | 2 | 2015 | 2533 | 0.240 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2009 | 937 | 0.230 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2007 | 433 | 0.220 |
Why?
|
| Ureteral Neoplasms | 2 | 2015 | 108 | 0.220 |
Why?
|
| Urinary Tract Infections | 2 | 2015 | 806 | 0.190 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 3484 | 0.190 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2009 | 1536 | 0.180 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2279 | 0.180 |
Why?
|
| Alcoholic Intoxication | 1 | 2001 | 176 | 0.180 |
Why?
|
| Learning | 1 | 2009 | 1762 | 0.170 |
Why?
|
| Markov Chains | 2 | 2013 | 977 | 0.160 |
Why?
|
| Costs and Cost Analysis | 2 | 2015 | 1670 | 0.150 |
Why?
|
| Postoperative Complications | 3 | 2015 | 15879 | 0.150 |
Why?
|
| Catheter Ablation | 1 | 2011 | 2775 | 0.140 |
Why?
|
| Hospital Costs | 2 | 2014 | 959 | 0.140 |
Why?
|
| Urodynamics | 1 | 1999 | 348 | 0.140 |
Why?
|
| Connective Tissue | 1 | 1999 | 425 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2015 | 9425 | 0.130 |
Why?
|
| Accidents, Traffic | 1 | 2001 | 821 | 0.130 |
Why?
|
| Collagen | 3 | 1999 | 2646 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 3253 | 0.120 |
Why?
|
| Urethral Stricture | 1 | 2015 | 51 | 0.120 |
Why?
|
| Kidney | 2 | 2007 | 7064 | 0.120 |
Why?
|
| Muscle, Smooth | 1 | 1999 | 930 | 0.120 |
Why?
|
| Retrospective Studies | 15 | 2015 | 81835 | 0.110 |
Why?
|
| Direct Service Costs | 1 | 2014 | 61 | 0.110 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2014 | 55 | 0.110 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2014 | 81 | 0.110 |
Why?
|
| Hematuria | 1 | 2014 | 233 | 0.100 |
Why?
|
| Male | 26 | 2015 | 364761 | 0.100 |
Why?
|
| Hospital Charges | 1 | 2013 | 351 | 0.100 |
Why?
|
| United States | 10 | 2015 | 73120 | 0.100 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2015 | 3550 | 0.090 |
Why?
|
| Databases, Factual | 4 | 2014 | 8081 | 0.090 |
Why?
|
| Humans | 33 | 2023 | 768369 | 0.090 |
Why?
|
| Medicare | 1 | 2009 | 6880 | 0.090 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 591 | 0.090 |
Why?
|
| Prostatic Hyperplasia | 1 | 2014 | 523 | 0.080 |
Why?
|
| Urology | 1 | 2015 | 411 | 0.080 |
Why?
|
| Diffusion of Innovation | 1 | 2014 | 730 | 0.080 |
Why?
|
| Compliance | 2 | 1999 | 100 | 0.080 |
Why?
|
| Capsule Endoscopy | 1 | 2009 | 106 | 0.080 |
Why?
|
| Insurance Claim Reporting | 1 | 2009 | 166 | 0.080 |
Why?
|
| Combined Modality Therapy | 3 | 2014 | 8559 | 0.080 |
Why?
|
| Hospitalization | 2 | 2013 | 10845 | 0.070 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2013 | 617 | 0.070 |
Why?
|
| Tomography | 1 | 2009 | 442 | 0.070 |
Why?
|
| Laser Therapy | 1 | 2014 | 1107 | 0.070 |
Why?
|
| Watchful Waiting | 1 | 2011 | 496 | 0.070 |
Why?
|
| Cystostomy | 1 | 2006 | 25 | 0.070 |
Why?
|
| Prescriptions | 1 | 2009 | 387 | 0.070 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2013 | 798 | 0.070 |
Why?
|
| Aged | 12 | 2015 | 171514 | 0.070 |
Why?
|
| Anti-Infective Agents, Urinary | 1 | 2006 | 28 | 0.070 |
Why?
|
| Disease-Free Survival | 3 | 2014 | 6856 | 0.070 |
Why?
|
| Treatment Outcome | 7 | 2015 | 65408 | 0.070 |
Why?
|
| Length of Stay | 3 | 2015 | 6521 | 0.060 |
Why?
|
| Propensity Score | 1 | 2014 | 1970 | 0.060 |
Why?
|
| Cryosurgery | 1 | 2011 | 477 | 0.060 |
Why?
|
| Cattle | 4 | 1999 | 3830 | 0.060 |
Why?
|
| Decision Support Techniques | 2 | 2013 | 2010 | 0.060 |
Why?
|
| Middle Aged | 14 | 2015 | 223406 | 0.060 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2011 | 1734 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 3 | 2013 | 5532 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 4931 | 0.060 |
Why?
|
| Prognosis | 5 | 2015 | 30031 | 0.060 |
Why?
|
| Ureter | 1 | 2006 | 370 | 0.060 |
Why?
|
| Cost Savings | 1 | 2009 | 917 | 0.060 |
Why?
|
| Patient Readmission | 2 | 2015 | 3308 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2014 | 2239 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2009 | 1218 | 0.050 |
Why?
|
| Suicide | 1 | 2014 | 1608 | 0.050 |
Why?
|
| Infant | 3 | 2013 | 36496 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 14725 | 0.050 |
Why?
|
| Drug Utilization | 1 | 2009 | 1192 | 0.050 |
Why?
|
| Mycoses | 1 | 2006 | 386 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 11844 | 0.050 |
Why?
|
| Organ Size | 1 | 2007 | 2268 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2013 | 42620 | 0.050 |
Why?
|
| Female | 15 | 2015 | 396926 | 0.050 |
Why?
|
| Inpatients | 1 | 2013 | 2561 | 0.050 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 1943 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2009 | 2437 | 0.050 |
Why?
|
| Forecasting | 1 | 2011 | 2950 | 0.050 |
Why?
|
| Health Expenditures | 1 | 2014 | 2391 | 0.050 |
Why?
|
| Depressive Disorder | 1 | 2014 | 3738 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2013 | 2562 | 0.050 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2006 | 640 | 0.050 |
Why?
|
| Risk Factors | 4 | 2014 | 74915 | 0.040 |
Why?
|
| Reference Values | 1 | 2007 | 4941 | 0.040 |
Why?
|
| Health Surveys | 1 | 2010 | 4056 | 0.040 |
Why?
|
| Pennsylvania | 1 | 2001 | 616 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 2291 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 36840 | 0.040 |
Why?
|
| Adolescent | 5 | 2014 | 89163 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 11249 | 0.040 |
Why?
|
| Glasgow Coma Scale | 1 | 2001 | 581 | 0.040 |
Why?
|
| Anxiety | 1 | 2014 | 4655 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2006 | 1424 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2014 | 3858 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2006 | 1397 | 0.040 |
Why?
|
| Elastic Tissue | 1 | 1998 | 66 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2014 | 9687 | 0.040 |
Why?
|
| Injury Severity Score | 1 | 2001 | 1053 | 0.040 |
Why?
|
| Time Factors | 2 | 2009 | 40271 | 0.040 |
Why?
|
| Cisplatin | 2 | 2014 | 1661 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 5709 | 0.040 |
Why?
|
| Child | 3 | 2013 | 80856 | 0.030 |
Why?
|
| Crohn Disease | 1 | 2009 | 2292 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2007 | 26394 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2009 | 3266 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2010 | 3230 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2001 | 950 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2015 | 5952 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1998 | 2298 | 0.030 |
Why?
|
| Perioperative Period | 1 | 2015 | 252 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1998 | 835 | 0.030 |
Why?
|
| Age Factors | 3 | 2014 | 18477 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 1999 | 2696 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 15459 | 0.030 |
Why?
|
| Gestational Age | 2 | 1999 | 3615 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 1998 | 1680 | 0.030 |
Why?
|
| Hematocrit | 1 | 2014 | 625 | 0.030 |
Why?
|
| Decision Trees | 1 | 2014 | 510 | 0.020 |
Why?
|
| Urothelium | 1 | 2014 | 275 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 1998 | 1977 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 20232 | 0.020 |
Why?
|
| Adult | 6 | 2015 | 223528 | 0.020 |
Why?
|
| Carboplatin | 1 | 2014 | 798 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2014 | 676 | 0.020 |
Why?
|
| Fetus | 1 | 1998 | 1883 | 0.020 |
Why?
|
| Survival Rate | 2 | 2014 | 12875 | 0.020 |
Why?
|
| Logistic Models | 2 | 2014 | 13323 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2007 | 22286 | 0.020 |
Why?
|
| Models, Economic | 1 | 2013 | 717 | 0.020 |
Why?
|
| SEER Program | 1 | 2014 | 1476 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2014 | 1794 | 0.020 |
Why?
|
| Morbidity | 1 | 2014 | 1760 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2014 | 2655 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 1998 | 11139 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2014 | 1308 | 0.020 |
Why?
|
| Kidney Calices | 1 | 2006 | 26 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2014 | 1737 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1997 | 3612 | 0.020 |
Why?
|
| Incidence | 2 | 2014 | 21552 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 6242 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 1544 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2013 | 2930 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 3637 | 0.020 |
Why?
|
| Registries | 1 | 2001 | 8372 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2014 | 6353 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2013 | 1960 | 0.010 |
Why?
|
| Reoperation | 1 | 2014 | 4342 | 0.010 |
Why?
|
| Young Adult | 3 | 2014 | 60038 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2014 | 2896 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 39429 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2014 | 3954 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2015 | 41782 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2014 | 5371 | 0.010 |
Why?
|
| Mental Health | 1 | 2014 | 3271 | 0.010 |
Why?
|
| Animals | 4 | 1999 | 169424 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 59679 | 0.010 |
Why?
|
| Radiography | 1 | 2009 | 6995 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 1998 | 66 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1998 | 420 | 0.010 |
Why?
|
| Contractile Proteins | 1 | 1998 | 240 | 0.010 |
Why?
|
| Pregnancy | 1 | 1999 | 30179 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 10358 | 0.010 |
Why?
|
| Elastin | 1 | 1998 | 299 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1997 | 565 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 9066 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 1998 | 1136 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 20763 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 54913 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1997 | 12813 | 0.000 |
Why?
|
Concepts
(197)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_